Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution

J Linden, HE Taylor, AS Robeva, AL Tucker, JH Stehle, SA Rivkees, JS Fink and SM Reppert

Laboratory of Developmental Chronobiology, Massachusetts General Hospital, Boston.

Using the polymerase chain reaction, an A3 adenosine receptor has been cloned from the hypophysial par tuberalis of sheep. The clone encodes a 317-amino acid protein that is 72% identical to the rat A3 adenosine receptor. In contrast to rat, where abundant A3 mRNA transcript is found primarily in testis, the sheep transcript is most abundant in lung, spleen, and pineal gland and is present in moderate levels in brain, kidney, and testis. The agonist N6- amino[125I]iodobenzyladenosine binds with high affinity (Kd congruent to 6 nm) and specificity to recombinant A3 adenosine receptors expressed transiently in COS-1 cells or stably in CHO K1 cells. The potency order of agonists is N6-aminoiodobenzyladenosine > N- ethylcarboxamidoadenosine > or = (R)-phenylisopropyladenosine >> cyclopentyladenosine. Little or no binding of purine nucleotides was detected. The potency order of antagonists is 3-(3-iodo-4-aminobenzyl)- 8-(4-oxyacetate)phenyl-1- propylxanthine (I-ABOPX) (Ki = 3 nM) > 1,3- dipropyl-8-(4-acrylate)phenylxanthine (BW-A1433) > 1,3-dipropyl-8- sulfophenylxanthine = xanthine amine cogener >> 8-cyclopentyl-1,3- dipropylxanthine. Enprofylline does not bind. These data indicate that, in contrast to A1 adenosine receptors, A3 adenosine receptors preferentially bind ligands with aryl rings in the N6-position of adenine and in the C8-position of xanthine. Among antagonists, the A3 adenosine receptor preferentially binds 8-phenylxanthines with acidic versus basic para-substituents (I-ABOPX > BW-A1433 > 1,3-dipropyl-8- sulfophenylxanthine = xanthine amine cogener). Agonists reduce forskolin-stimulated cAMP accumulation in Chinese hamster ovary cells stably transfected with recombinant sheep A3 adenosine receptors; the reduction is blocked by BW-A1433 but not by 8-cyclopentyl-1,3- dipropylxanthine. These data suggest that (i) A3 adenosine receptors display unusual structural diversity for species homologs, (ii) in contrast to rat, sheep A3 adenosine receptors have a broad tissue distribution, and (iii) some xanthines with acidic side chains bind with high affinity to A3 adenosine receptors.

Volume 44, Issue 3, pp. 524-532, 09/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. E. Wunderlich, B. J. Needleman, Z. Chen, J. G. Yu, Y. Wang, I. Grants, D. J. Mikami, W. S. Melvin, H. J. Cooke, and F. L. Christofi Dual purinergic synaptic transmission in the human enteric nervous system Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G554 - G566. [Abstract] [Full Text] [PDF]

				V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]

				R. Yaar, L. M. Cataldo, A. Tzatsos, C. E. Francis, Z. Zhao, and K. Ravid Regulation of the A3 Adenosine Receptor Gene in Vascular Smooth Muscle Cells: Role of a cAMP and GATA Element Mol. Pharmacol., November 1, 2002; 62(5): 1167 - 1176. [Abstract] [Full Text] [PDF]

				R. G. Black Jr, Y. Guo, Z.-D. Ge, S. S. Murphree, S. D. Prabhu, W. K. Jones, R. Bolli, and J. A. Auchampach Gene Dosage-Dependent Effects of Cardiac-Specific Overexpression of the A3 Adenosine Receptor Circ. Res., July 26, 2002; 91(2): 165 - 172. [Abstract] [Full Text] [PDF]

				S. Gessi, K. Varani, S. Merighi, E. Cattabriga, V. Iannotta, E. Leung, P. G. Baraldi, and P. A. Borea A3 Adenosine Receptors in Human Neutrophils and Promyelocytic HL60 Cells: A Pharmacological and Biochemical Study Mol. Pharmacol., February 1, 2002; 61(2): 415 - 424. [Abstract] [Full Text] [PDF]

				L. J. Murphree, M. A. Marshall, J. M. Rieger, T. L. MacDonald, and J. Linden Human A2A Adenosine Receptors: High-Affinity Agonist Binding to Receptor-G Protein Complexes Containing Gbeta 4 Mol. Pharmacol., February 1, 2002; 61(2): 455 - 462. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				R. J. Cerniway, Z. Yang, M. A. Jacobson, J. Linden, and G. P. Matherne Targeted deletion of A3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1751 - H1758. [Abstract] [Full Text] [PDF]

				R. Zucchi, G. Yu, S. Ghelardoni, F. Ronca, and S. Ronca-Testoni A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart Cardiovasc Res, April 1, 2001; 50(1): 56 - 64. [Abstract] [Full Text] [PDF]

				G. Ferguson, K. R. Watterson, and T. M. Palmer Subtype-Specific Kinetics of Inhibitory Adenosine Receptor Internalization Are Determined by Sensitivity to Phosphorylation by G Protein-Coupled Receptor Kinases Mol. Pharmacol., March 1, 2000; 57(3): 546 - 552. [Abstract] [Full Text]

				C. A. Salvatore, S. L. Tilley, A. M. Latour, D. S. Fletcher, B. H. Koller, and M. A. Jacobson Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells J. Biol. Chem., February 11, 2000; 275(6): 4429 - 4434. [Abstract] [Full Text] [PDF]

				J. E. Jordan, V. H. Thourani, J. A. Auchampach, J. A. Robinson, N.-P. Wang, and J. Vinten-Johansen A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1895 - H1905. [Abstract] [Full Text] [PDF]

				R. D. Lasley, P. Narayan, M. S. Jahania, E. L. Partin, K. R. Kraft, and R. M. Mentzer Jr. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2076 - H2084. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				E. C. Mun, K. J. Tally, and J. B. Matthews Characterization and regulation of adenosine transport in T84 intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 1998; 274(2): G261 - G269. [Abstract] [Full Text] [PDF]

				I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]

				J. A. Auchampach, X. Jin, T. C. Wan, G. H. Caughey, and J. Linden Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor Mol. Pharmacol., November 1, 1997; 52(5): 846 - 860. [Abstract] [Full Text]

				T. M. Palmer, C. A. Harris, J. Coote, and G. L. Stiles Induction of Multiple Effects on Adenylyl Cyclase Regulation by Chronic Activation of the Human A3 Adenosine Receptor Mol. Pharmacol., October 1, 1997; 52(4): 632 - 640. [Abstract] [Full Text]

				J. A. Auchampach, A. Rizvi, Y. Qiu, X.-L. Tang, C. Maldonado, S. Teschner, and R. Bolli Selective Activation of A3 Adenosine Receptors With N6-(3-Iodobenzyl)Adenosine-5'-N-Methyluronamide Protects Against Myocardial Stunning and Infarction Without Hemodynamic Changes in Conscious Rabbits Circ. Res., June 19, 1997; 80(6): 800 - 809. [Abstract] [Full Text]

				R. J. Hill, J. J. Oleynek, C. F. Hoth, M. A. R. Kiron, W. Weng, R. T. Wester, W. R. Tracey, D. R. Knight, R. A. Buchholz, and S. P. Kennedy Cloning, Expression and Pharmacological Characterization of Rabbit Adenosine A1 and A3 Receptors J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 122 - 128. [Abstract] [Full Text]

				R. K. Shepherd, J. Linden, and B. R. Duling Adenosine-Induced Vasoconstriction In Vivo : Role of the Mast Cell and A3 Adenosine Receptor Circ. Res., April 1, 1996; 78(4): 627 - 634. [Abstract] [Full Text]

				T. M. Palmer, J. L. Benovic, and G. L. Stiles Agonist-dependent Phosphorylation and Desensitization of the Rat A(3) Adenosine Receptor J. Biol. Chem., December 8, 1995; 270(49): 29607 - 29613. [Abstract] [Full Text] [PDF]

				T. M. Palmer, T. W. Gettys, and G. L. Stiles Differential Interaction with and Regulation of Multiple G-proteins by the Rat A[IMAGE] Adenosine Receptor J. Biol. Chem., July 14, 1995; 270(28): 16895 - 16902. [Abstract] [Full Text] [PDF]

				G. R. Strohmeier, S. M. Reppert, W. I. Lencer, and J. L. Madara The A[IMAGE] Adenosine Receptor Mediates cAMP Responses to Adenosine Receptor Agonists in Human Intestinal Epithelia J. Biol. Chem., February 3, 1995; 270(5): 2387 - 2394. [Abstract] [Full Text] [PDF]